National Notifiable Diseases Surveillance System, 1 January to 31 March 2014

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the reporting period 1 January to 31 March 2014.

Page last updated: 25 August 2014

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 57,805 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 January to 31 March 2014 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).
NEC Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
 All jurisdictions
Hepatitis B (newly acquired)
 All jurisdictions
Hepatitis B (unspecified)
 All jurisdictions
Hepatitis C (newly acquired)
 All jurisdictions except Queensland
Hepatitis C (unspecified)
 All jurisdictions
Hepatitis D
 All jurisdictions
Gastrointestinal diseases
Botulism
 All jurisdictions
Campylobacteriosis
 All jurisdictions except New South Wales
Cryptosporidiosis
 All jurisdictions
Haemolytic uraemic syndrome
 All jurisdictions
Hepatitis A
 All jurisdictions
Hepatitis E
 All jurisdictions
Listeriosis
 All jurisdictions
STEC, VTEC*
 All jurisdictions
Salmonellosis
 All jurisdictions
Shigellosis
 All jurisdictions
Typhoid
 All jurisdictions
Quarantinable diseases
Cholera
 All jurisdictions
Highly pathogenic avian influenza in humans
 All jurisdictions
Plague
 All jurisdictions
Rabies
 All jurisdictions
Severe acute respiratory syndrome
 All jurisdictions
Smallpox
 All jurisdictions
Viral haemorrhagic fever
 All jurisdictions
Yellow fever
 All jurisdictions
Sexually transmissible infections
Chlamydial infection
 All jurisdictions
Donovanosis
 All jurisdictions
Gonococcal infection
 All jurisdictions
Syphilis - congenital
 All jurisdictions
Syphilis <2 years duration
 All jurisdictions
Syphilis >2 years or unspecified duration
 All jurisdictions
Vaccine preventable diseases
Diphtheria
 All jurisdictions
Haemophilus influenzae type b
 All jurisdictions
Influenza (laboratory confirmed)
 All jurisdictions
Measles
 All jurisdictions
Mumps
 All jurisdictions
Pertussis
 All jurisdictions
Pneumococcal disease (invasive)
 All jurisdictions
Poliomyelitis
 All jurisdictions
Rubella
 All jurisdictions
Rubella - congenital
 All jurisdictions
Tetanus
 All jurisdictions
Varicella zoster (chickenpox)
 All jurisdictions except New South Wales
Varicella zoster (shingles)
 All jurisdictions except New South Wales
Varicella zoster (unspecified)
 All jurisdictions except New South Wales
Vectorborne diseases
Arbovirus infection (NEC)
 All jurisdictions
Barmah Forest virus infection
 All jurisdictions
Dengue virus infection
 All jurisdictions
Japanese encephalitis virus infection
 All jurisdictions
Kunjin virus infection
 All jurisdictions
Malaria
 All jurisdictions
Murray Valley encephalitis virus infection
 All jurisdictions
Ross River virus infection
 All jurisdictions
Zoonoses
Anthrax
 All jurisdictions
Australian bat lyssavirus
 All jurisdictions
Brucellosis
 All jurisdictions
Leptospirosis
 All jurisdictions
Lyssavirus (NEC)
 All jurisdictions
Ornithosis
 All jurisdictions
Q fever
 All jurisdictions
Tularaemia
 All jurisdictions
Other bacterial infections
Legionellosis
 All jurisdictions
Leprosy
 All jurisdictions
Meningococcal infection
 All jurisdictions
Tuberculosis
 All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 January to 31 March 2014, by date of diagnosis*
  State or territory Total 1st quarter 2014 Total 4th quarter 2013 Total 1st quarter 2013 Last 5 years mean 1st quarter Ratio Year to date 2014 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas Vic WA

* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

¶ The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Hepatitis B (newly acquired)†
0
11
1
17
4
1
16
7
57
40
47
55.8
1.0
57
55.8
Hepatitis B (unspecified)‡
24
668
43
235
82
17
399
162
1,630
1,675
1,590
1,705.6
1.0
1,630
1,705.6
Hepatitis C (newly acquired)†
2
8
1
0
12
3
30
39
95
109
117
110.2
0.9
95
110.2
Hepatitis C (unspecified)‡
43
885
48
649
82
61
497
226
2,491
2,532
2,432
2,614.8
1.0
2,491
2,614.8
Hepatitis D
0
1
0
5
0
0
4
0
10
13
15
9.8
1.0
10
9.8
Gastrointestinal diseases
Botulism
0
0
0
0
0
0
0
0
0
0
2
0.6
0.0
0
0.6
Campylobacteriosis
139
NN
75
1,380
360
253
1,953
606
4,766
4,400
3,481
4,303.0
1.1
4,766
4,303.0
Cryptosporidiosis
22
145
34
271
71
5
195
113
856
567
1,727
1,439.8
0.6
856
1,439.8
Haemolytic uraemic syndrome
0
3
0
1
2
1
2
0
9
6
4
4.4
2.0
9
4.4
Hepatitis A
2
27
1
16
5
0
26
8
85
33
69
65.4
1.3
85
65.4
Hepatitis E
0
6
0
1
0
0
2
0
9
8
15
14.4
0.6
9
14.4
Listeriosis
0
7
0
2
1
0
9
3
22
13
29
27.2
0.8
22
27.2
STEC, VTEC§
0
17
0
4
15
0
4
1
41
29
43
35.8
1.1
41
35.8
Salmonellosis
58
1,505
110
1,565
339
104
1,171
345
5,197
3,307
4,130
4,051.6
1.3
5,197
4,051.6
Shigellosis
10
77
23
45
11
0
125
25
316
161
144
174.4
1.8
316
174.4
Typhoid
0
14
0
11
3
0
13
3
44
35
68
49.6
0.9
44
49.6
Quarantinable diseases
Cholera
0
0
0
0
0
0
1
0
1
2
0
0.6
1.7
1
0.6
Highly pathogenic avian influenza in humans
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Plague
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rabies
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Smallpox
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Yellow fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Sexually transmissible infections
Chlamydial infection||,¶
297
6,136
717
5,440
1,372
440
5,064
3,032
22,498
19,565
21,033
19,803.0
1.1
22,498
19,803.0
Donovanosis
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Gonococcal infection
50
1,240
450
763
215
19
903
595
4,235
3,486
3,837
3,025.4
1.4
4,235
3,025.4
Syphilis – congenital
0
0
0
0
0
0
0
0
0
1
1
1.4
0.0
0
1.4
Syphilis < 2 years duration
5
153
6
96
6
1
174
18
459
425
447
362.2
1.3
459
362.2
Syphilis > 2 years or unspecified duration‡,¶
8
88
14
87
36
7
178
18
436
375
386
338.6
1.3
436
338.6
Vaccine preventable diseases
Diphtheria
0
0
0
0
0
0
0
0
0
1
1
0.2
0.0
0
0.2
Haemophilus influenzae type b
0
0
1
2
0
0
0
0
3
4
3
3.8
0.8
3
3.8
Influenza (laboratory confirmed)
47
721
247
1,321
487
50
568
380
3,821
6,127
2,331
1,441.2
2.7
3,821
1,441.2
Measles
1
49
47
15
10
0
34
17
173
85
10
38.0
4.6
173
38.0
Mumps
0
30
1
16
4
2
4
6
63
40
72
45.0
1.4
63
45.0
Pertussis
46
482
17
542
110
32
750
348
2,327
3,071
3,620
7,168.8
0.3
2,327
7,168.8
Pneumococcal disease (invasive)
3
69
11
29
18
3
51
29
213
324
212
215.8
1.0
213
215.8
Poliomyelitis
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rubella
0
3
0
1
1
0
0
1
6
5
1
12.2
0.5
6
12.2
Rubella – congenital
0
0
0
0
0
0
0
0
0
1
0
0.0
0.0
0
0.0
Tetanus
0
1
0
0
0
0
0
0
1
0
3
1.8
0.6
1
1.8
Varicella zoster (chickenpox)
15
NN
36
44
73
5
211
84
468
648
374
372.6
1.3
468
372.6
Varicella zoster (shingles)
10
NN
57
16
501
67
378
350
1,379
1,348
1,206
968.0
1.4
1,379
968.0
Varicella zoster (unspecified)
50
NN
1
1,500
55
41
816
315
2,778
2,686
2,250
1,913.8
1.5
2,778
1,913.8
Vectorborne diseases
Arbovirus infection (NEC)
0
2
0
13
0
0
0
0
15
4
5
3.4
4.4
15
3.4
Barmah Forest virus infection
0
57
7
244
0
0
2
21
331
442
1,423
746.4
0.4
331
746.4
Dengue virus infection
4
136
26
217
17
5
92
156
653
315
495
544.8
1.2
653
544.8
Japanese encephalitis virus infection
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.2
Kunjin virus infection**
0
0
0
1
0
0
0
0
1
3
0
0.6
1.7
1
0.6
Malaria
2
28
3
24
2
0
19
13
91
82
138
110.8
0.8
91
110.8
Murray Valley encephalitis virus infection**
0
0
0
0
0
0
0
0
0
0
0
2.2
0.0
0
2.2
Ross River virus infection
0
113
188
448
18
12
70
776
1,625
939
1,352
1,987.6
0.8
1,625
1,987.6
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.2
Australian bat lyssavirus
0
0
0
0
0
0
0
0
0
0
1
0.2
0.0
0
0.2
Brucellosis
0
0
0
5
0
0
1
0
6
4
5
7.2
0.8
6
7.2
Leptospirosis
0
4
1
21
0
0
0
0
26
22
15
54.2
0.5
26
54.2
Lyssavirus (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Ornithosis
0
4
0
1
0
0
4
2
11
15
7
14.0
0.8
11
14.0
Q fever
0
38
1
79
2
0
6
2
128
119
103
92.8
1.4
128
92.8
Tularaemia
0
0
0
0
0
0
0
0
0
0
0
0.3
0.0
0
0.3
Other bacterial infections
Legionellosis
0
19
4
14
11
1
15
23
87
118
98
81.4
1.1
87
81.4
Leprosy
0
1
0
0
0
0
0
2
3
4
2
1.2
2.5
3
1.2
Meningococcal infection††
0
4
2
9
4
0
4
3
26
32
39
44.4
0.6
26
44.4
Tuberculosis
7
105
5
46
11
2
101
36
313
312
315
317.8
1.0
313
317.8
Total
845
12,857
2,178
15,196
3,940
1,132
13,892
7,765
57,805
53,533
53,698
57,805

Top of page

Table 3: Notification rates of diseases, 1 January to 31 March 2014, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust
ACT NSW NT Qld SA Tas Vic WA

* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

** The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

‡‡ Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.
Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)‡
0.0
0.6
1.7
1.5
1.0
0.8
1.1
1.1
1.0
Hepatitis B (unspecified)§
25.8
37.0
73.1
20.7
20.1
13.6
28.5
26.4
28.9
Hepatitis C (newly acquired)‡
2.1
0.4
1.7
0.0
2.9
2.4
2.1
6.3
1.7
Hepatitis C (unspecified)§
46.2
49.0
81.6
57.2
20.1
48.7
35.5
36.8
44.1
Hepatitis D
0.0
0.1
0.0
0.4
0.0
0.0
0.3
0.0
0.2
Gastrointestinal diseases
Botulism
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis
149.4
NN
127.5
121.5
88.3
202.2
139.5
98.6
124.3
Cryptosporidiosis
23.6
8.0
57.8
23.9
17.4
4.0
13.9
18.4
15.2
Haemolytic uraemic syndrome
0.0
0.2
0.0
0.1
0.5
0.8
0.1
0.0
0.2
Hepatitis A
2.1
1.5
1.7
1.4
1.2
0.0
1.9
1.3
1.5
Hepatitis E
0.0
0.3
0.0
0.1
0.0
0.0
0.1
0.0
0.2
Listeriosis
0.0
0.4
0.0
0.2
0.2
0.0
0.6
0.5
0.4
STEC,VTEC||
0.0
0.9
0.0
0.4
3.7
0.0
0.3
0.2
0.7
Salmonellosis
62.3
83.3
187.0
137.8
83.2
83.1
83.7
56.1
92.1
Shigellosis
10.7
4.3
39.1
4.0
2.7
0.0
8.9
4.1
5.6
Typhoid fever
0.0
0.8
0.0
1.0
0.7
0.0
0.9
0.5
0.8
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
Human pathogenic avian influenza in humans
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydial infection¶,**
319.2
339.5
1,218.8
479.1
336.7
351.6
361.8
493.2
398.7
Donovanosis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection**
53.7
68.6
764.9
67.2
52.8
15.2
64.5
96.8
75.1
Syphilis – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Syphilis < 2 years duration**
5.4
8.5
10.2
8.5
1.5
0.8
12.4
2.9
8.1
Syphilis > 2 years or unspecified duration§,**
8.6
4.9
23.8
7.7
8.8
5.6
12.7
2.9
7.7
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.0
1.7
0.2
0.0
0.0
0.0
0.0
0.1
Influenza (laboratory confirmed)
50.5
39.9
419.9
116.3
119.5
40.0
40.6
61.8
67.7
Measles
1.1
2.7
79.9
1.3
2.5
0.0
2.4
2.8
3.1
Mumps
0.0
1.7
1.7
1.4
1.0
1.6
0.3
1.0
1.1
Pertussis
49.4
26.7
28.9
47.7
27.0
25.6
53.6
56.6
41.2
Pneumococcal disease (invasive)
3.2
3.8
18.7
2.6
4.4
2.4
3.6
4.7
3.8
Poliomyelitis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
0.0
0.2
0.0
0.1
0.2
0.0
0.0
0.2
0.1
Rubella – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)
16.1
NN
61.2
3.9
17.9
4.0
15.1
13.7
12.2
Varicella zoster (shingles)
10.7
NN
96.9
1.4
122.9
53.5
27.0
56.9
36.0
Varicella zoster (unspecified)
53.7
NN
1.7
132.1
13.5
32.8
58.3
51.2
72.4
Vectorborne diseases
Arbovirus infection (NEC)
0.0
0.1
0.0
1.1
0.0
0.0
0.0
0.0
0.3
Barmah Forest virus infection
0.0
3.2
11.9
21.5
0.0
0.0
0.1
3.4
5.9
Dengue virus infection
4.3
7.5
44.2
19.1
4.2
4.0
6.6
25.4
11.6
Japanese encephalitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Kunjin virus infection††
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
Malaria
2.1
1.5
5.1
2.1
0.5
0.0
1.4
2.1
1.6
Murray Valley encephalitis virus infection††
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
0.0
6.3
319.6
39.5
4.4
9.6
5.0
126.2
28.8
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.0
0.0
0.4
0.0
0.0
0.1
0.0
0.1
Leptospirosis
0.0
0.2
1.7
1.8
0.0
0.0
0.0
0.0
0.5
Lyssavirus (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.2
0.0
0.1
0.0
0.0
0.3
0.3
0.2
Q fever
0.0
2.1
1.7
7.0
0.5
0.0
0.4
0.3
2.3
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
0.0
1.1
6.8
1.2
2.7
0.8
1.1
3.7
1.5
Leprosy
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.3
0.1
Meningococcal infection‡‡
0.0
0.2
3.4
0.8
1.0
0.0
0.3
0.5
0.5
Tuberculosis
7.5
5.8
8.5
4.1
2.7
1.6
7.2
5.9
5.5

Top of page

In this section

CDI Search

Search Communicable Diseases Intelligence

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Surveillance